₹ 3.0 Cr
Volume transacted
194.0 K
stocks traded
Last Updated time: 26 Jul 15:30 PM
Alembic Ltd
NSE: ALEMBICLTD
DPS
₹ 2.4
Last updated : FY 2024
The Dividend per Share of Alembic Ltd is ₹ 2.4 as of 2024 .a1#The Dividend Payout of Alembic Ltd changed from 12.49 % on March 2019 to 66.35 % on March 2024 . This represents a CAGR of 32.09% over 6 years. a1#The Latest Trading Price of Alembic Ltd is ₹ 156.95 as of 26 Jul 15:30 .a1#The Market Cap of Alembic Ltd changed from ₹ 1084 crore on March 2019 to ₹ 2148 crore on March 2024 . This represents a CAGR of 12.06% over 6 years. a1#The Revenue of Alembic Ltd changed from ₹ 22.79 crore to ₹ 51.08 crore over 8 quarters. This represents a CAGR of 49.71% a1#The EBITDA of Alembic Ltd changed from ₹ 6.13 crore to ₹ 26.19 crore over 8 quarters. This represents a CAGR of 106.70% a1#The Net Pr of Alembic Ltd changed from ₹ 3.86 crore to ₹ 21.29 crore over 8 quarters. This represents a CAGR of 134.85% a1#
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Market Cap
₹ 3,937 Cr
EPS
₹ 10.4
P/E Ratio (TTM) *
14.7
P/B Ratio (TTM) *
1.8
DTE *
0.0
ROE *
12.3
ROCE *
4.7
Dividend Yield *
2.87
DPS *
2.4
Dividend Payout *
66.35
Ann.Dividend % *
120
* All values are consolidated
Last Updated time: 26 Jul 15:30 PM
* All values are consolidated
Last Updated time: 26 Jul 15:30 PM
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Period | |
---|---|
Mar '19 | 12 |
Mar '20 | 16 |
Mar '21 | 38 |
Mar '22 | 54 |
Mar '23 | 71 |
Mar '24 | 66 |
* All values are a in %
Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.
* All values are in %
Alembic Ltd
NSE: ALEMBICLTD
PRICE
₹ 156.95
3.60 (2.35%)
Last updated : 26 Jul 15:30
Strength
2
S
Weakness
2
W
Opportunity
0
O
Threats
1
T
A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.
A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.
Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.
A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Period | |
---|---|
Mar '19 | 1085 |
Mar '20 | 917 |
Mar '21 | 2641 |
Mar '22 | 1858 |
Mar '23 | 1522 |
Mar '24 | 2148 |
* All values are a in ₹crore
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Period | |
---|---|
Jun '22 | 23 |
Sep '22 | 97 |
Dec '22 | 33 |
Mar '23 | 39 |
Jun '23 | 39 |
Sep '23 | 80 |
Dec '23 | 42 |
Mar '24 | 51 |
* All values are a in ₹crore
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Period | |
---|---|
Jun '22 | 6 |
Sep '22 | 70 |
Dec '22 | 13 |
Mar '23 | 5 |
Jun '23 | 14 |
Sep '23 | 58 |
Dec '23 | 14 |
Mar '24 | 26 |
* All values are a in ₹crore
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Period | |
---|---|
Jun '22 | 4 |
Sep '22 | 61 |
Dec '22 | 11 |
Mar '23 | 5 |
Jun '23 | 10 |
Sep '23 | 52 |
Dec '23 | 10 |
Mar '24 | 21 |
* All values are a in ₹crore
Alembic Ltd is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara. The Company has been dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business. The company is a ISO-9002 and ISO-14001 certified company with manufacturing practices and facilities that conform to WHO-GMP guidelines. They manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. They are having their manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh. Alembic Ltd was incorporated in the year 1907 with the name Alembic Chemical Works Co Ltd in Vadodara to manufacture tinctures and alcohol. They Started to manufacture cough syrup, vitamins, tonics and sulphur durgs in the year 1940. In the year 1961, they inaugrated the Pencillin Palnt. In the year 1968, they started to manufacture Streptomycin. In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In June 2001, the company formed a wholly owned subsidiary company named Alembic Europe Pvt Ltd in UK. In the year 2005, the company has launched ZERO, a new generation, no calories, Sucralose Based Sugar Substitute which gave entry for the company into the high-growth lifestyle OTC product segment. In May 2005, the generic alliances and API division were merged to form an independent SBU. The company has set up a formulation manufacturing facility at Baddi in Himachal Pradesh with a production capacity 900 million tablets and 600 million liquid oral bottles annually. During the year 2005-06, the company has increased the installed capacity of Tablets & Capsules and Oral Preparation & Ointments by 595 Million Nos and 720 MT respectively. During the year 2005-06, the company acquired API Plant at Karakhadi in Vadodara. In the year 2007, the company acquired the Non-Oncology Business of Dabur Pharma Ltd. Also in the same year, they entered into a licensing agreement for its Novel Drug Delivery Platform for Keppra XR with UCB Belgium. During the year 2007-08, the company acquired the API manufacturing facility of Nirayu Pvt Ltd at Panelav near Vododara. The Company formed a wholly owned subsidiary viz. Alembic Global Holding SA in Neuchatel, Switzerland in 2009. The 'Pharmaceutical Undertaking' of the Company demerged and the same got transferred to Alembic Pharmaceuticals Limited with effect from Appointed date i.e. 1st April, 2010. The maiden real estate project -'Samsara' was completed in 2014. The Company launched second real estate project, VEDA in 2015-16. It further launched two API's in 2017. During year 2017-18, Alembic City Limited (formerly known as Alembic Exports Limited) became wholly-owned subsidiary of the Company. During 2018-19, the Composite Scheme of Arrangement comprising of transfer and vesting of the Identified Real Estate Undertaking of Alembic Limited (the Company / the First Demerged Company) into Shreno Limited (the First Transferee Company/ the Second Demerged Company) and transfer and vesting of Engineering Division and Investment Division of Shreno Limited into Nirayu Private Limited (the Second Transferee Company) and their respective shareholders with effect from the Appointed Date i.e. 1st November, 2018 was sanctioned by the Hon'ble National Company Law Tribunal, Ahmedabad Bench (NCLT') vide its order dated 26th July, 2019. Accordingly, Scheme was made effective from 26th July, 2019. The Company launched a residential project VEDA - II during 2020.
Alembic to convene AGM
Alembic announced that the 117th Annual General Meeting (AGM) of the company will be held ...
Read more
17 Jun 202409:28
Board of Alembic recommends final dividend
Alembic announced that the Board of Directors of the Company at its meeting held on 13 May...
Read more
14 May 202409:41
Alembic to table results
Alembic will hold a meeting of the Board of Directors of the Company on 13 May 2024. Power...
Read more
03 May 202417:11
ICRA reaffirms ratings of Alembic with 'stable' outlook
The agency has reaffirmed its short-term rating on the debt instruments of Alembic at ‘[IC...
Read more
29 Feb 202413:55
Alembic to announce Quarterly Result
Alembic will hold a meeting of the Board of Directors of the Company on 14 February 2024. ...
Read more
06 Feb 202411:41
Alembic announces board meeting date
Alembic will hold a meeting of the Board of Directors of the Company on 8 November 2023. P...
Read more
31 Oct 202315:19
FAQs for dividends of Alembic Ltd
What is the current market price of Alembic Ltd Ltd as of July 26, 2024?
What dividend did Alembic Ltd declare in the last fiscal year?
What is the most recent dividend declared by Alembic Ltd?
How many times has Alembic Ltd declared dividends in the current fiscal year
How many times did Alembic Ltd declare dividends in the previous fiscal year?
Unlimited trading at just
Rs. 199